Hospital at Home - Regional remote monitoring of severely ill patients
| Reference number | |
| Coordinator | Region Stockholm - Karolinska Universitetssjukhuset Tema HKN |
| Funding from Vinnova | SEK 16 000 000 |
| Project duration | December 2023 - January 2026 |
| Status | Ongoing |
| Venture | Challengedriven innovation - Phase 3 Implementation |
| Call | Challenge-driven innovation - Step 3 Implementation 2023 - autumn |
Purpose and goal
The aim is to increase the possibility of hospital care at home for acutely and chronically ill people, to earlier detect deterioration, increase the patient´s prognosis, optimize the patient before intervention and enable treatment at home when the patient is stable. The goal is regionally coordinated home monitoring with effective collaboration across care organizations, centralized monitoring functions and centralized management of technical solutions, functioning reimbursement/business models as well as technical data-driven solutions that minimize lock-in effects.
Expected effects and result
Expected effects: reduced need for acute and inpatient care, increased quality of life, patient involvement and self-care, fewer complications and shorter treatment times. Expected results: Monitoring centers in four hospitals are up and running and are ready for implementation. Technology solution management function ready. Partnership with one or more technology suppliers including business models for health care and technology suppliers. Clear aim of how to transform towards data-driven technical solutions that reduce lock-in effects.
Planned approach and implementation
Three major challenges to overcome for successful implementation and scalability: monitoring centers with competence to follow large patient volumes, collaboration across healthcare organizations and centralized management of technical solutions. Pilots are the hub of the project, i.e. tools (test beds) for the further development of hospital care at home. Each healthcare provider is responsible for the implementation of their pilots and necessary monitoring. The collaboration with 3 suppliers from Stage 2 continues, but can be supplemented with additional suppliers.